Carpal tunnel syndrome (CTS) is the most recognized occupational maladies as well as one of the most reported. Marked by numbness, weakness, and pain in the wrist and hand particularly the thumb and index finger, and frequently shooting up the arm CTS occurs when the median nerve, which runs from the forearm to the base of the palm, becomes compressed. This constriction or pinching is commonly attributed to repetitive motion and stress. Yet, in spite of its association with heavy computer use, carpal tunnel syndrome is not confined to data entry workers. Butchers, mechanics, musicians, dental hygienists, tennis players and golfers are vulnerable. According to recent studies, CTS affects about 3 percent of the general population, whether on the job or at play. Women are more likely than men to develop it. Individuals with rheumatoid arthritis are also at high risk.
Despite the prevalence of CTS and its considerable economic impact in terms of both worker absenteeism and compensation claims there is no universally accepted therapy. Mild cases are usually left untreated. Moderate cases may be treated with local injections of corticosteroids, if patients fail to respond to splinting and anti-inflammatory drugs like ibuprofen. In severe cases, with the threat of permanent loss of sensation, the preferred treatment is surgery. Surgery, however, is often recommended to patients before trying less invasive and less expensive treatments. Is surgery always the best course for carpal tunnel syndrome's sufferers? A team of researchers in Madrid recently set out to find the answer. The results of their clinical trial, published in the February 2005 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/journal/arthritis), suggest that local steroid injection is just as effective as surgery for the long-term symptomPage: 1 2 3 Related medicine news :1
Contact: Amy Molnar
John Wiley & Sons, Inc.
. Optimal time to treat migraine pain with Relpax; is early in the attack, new study finds2
. Hormonal treatment improves survival in high-risk prostate cancer patients3
. Chronic pain treatments more effective when taken together, new study shows4
. Brain activity prior to treatment flags vulnerability to antidepressant side effects5
. Cultural and social factors influence prostate cancer treatment6
. Research offers hope of new treatments for liver damage7
. First mouse model for multiple system atrophy points to new treatment targets for brain diseases8
. Stanford patient is first to test new treatment for peripheral arterial disease9
. Scientist works on innovative treatments for brain tumors10
. Blacks less likely to get expensive, newer heart treatments11
. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women